Antarka Bio

Montevideo, Uruguay

Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions.

$3.5M raised

Feb 2026

Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Antarka Bio raised?

Antarka Bio has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in February 2026.

Who are Antarka Bio's investors?

Antarka Bio's investors include GS Futures, SOSV, SOSV SF & NY (Fka IndieBio), Zentynel Frontier Investments, Natura Ventures.

Where is Antarka Bio headquartered?

Antarka Bio is headquartered in Montevideo, Uruguay.

What does Antarka Bio do?

Antarka develops Antarctic-derived enzymes that repair UV-damaged skin DNA, powering next-generation anti-aging and skin health solutions.

What stage is Antarka Bio at?

Antarka Bio is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 9, 2026.

MLA

"Antarka Bio — Funding & Investors." VCBacked, February 9, 2026, https://www.vcbacked.co/company/antarka-bio. Accessed July 2, 2026.

APA

VCBacked. (2026). Antarka Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/antarka-bio

Wikipedia (cite web)

{{cite web |title=Antarka Bio — Funding & Investors |url=https://www.vcbacked.co/company/antarka-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 9, 2026.